Welcome to LookChem.com Sign In|Join Free

CAS

  • or

22308-12-9

Post Buying Request

22308-12-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

22308-12-9 Usage

General Description

1,3-BIS(TOSYLOXY)-2,2-DIMETHYLPROPANE, also known as di-p-toluenesulfonyloxymethylpropane, is a chemical compound commonly used as a reagent in organic synthesis. It is a colorless liquid with a strong, pungent odor, and it is highly flammable. 1,3-BIS(TOSYLOXY)-2,2-DIMETHYLPROPANE is known for its ability to act as a strong acid catalyst and is often used in the synthesis of various organic compounds. It is also used as a reagent in the preparation of pharmaceuticals and agrochemicals. Additionally, this chemical is known for its potential environmental and health hazards, and proper safety precautions should be taken when handling and storing it.

Check Digit Verification of cas no

The CAS Registry Mumber 22308-12-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,3,0 and 8 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 22308-12:
(7*2)+(6*2)+(5*3)+(4*0)+(3*8)+(2*1)+(1*2)=69
69 % 10 = 9
So 22308-12-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H24O6S2/c1-15-5-9-17(10-6-15)26(20,21)24-13-19(3,4)14-25-27(22,23)18-11-7-16(2)8-12-18/h5-12H,13-14H2,1-4H3

22308-12-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name [2,2-dimethyl-3-(4-methylphenyl)sulfonyloxypropyl] 4-methylbenzenesulfonate

1.2 Other means of identification

Product number -
Other names Neopentyl Glycol Ditosylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:22308-12-9 SDS

22308-12-9Relevant articles and documents

Probing hyperconjugation experimentally with the conformational deuterium isotope effect

Greenway, Kyle T.,Bischoff, Anthony G.,Pinto, B. Mario

, p. 9221 - 9226,6 (2012)

Hyperconjugation underlies many chemical phenomena of fundamental and practical importance. Owing to a great deal of interest in the anomeric effect, anomeric-like hyperconjugative effects have been thoroughly investigated in oxygen-containing systems. However, such interactions in the second- and third-row chalcogens are less well-understood and have generated some controversy. Here, we show that the conformational deuterium isotope effect, in combination with Saunders isotopic perturbation method, permits sensitive and direct experimental probing of the conformational equilibria in dioxane, dithiane, and diselenane analogues by variable-temperature, dynamic NMR spectroscopy. We find that the magnitude of the conformational deuterium isotope effect is 252.1, 28.3, and 7.1 J/mol (±10%) for the oxygen, sulfur, and selenium analogues, respectively. These results reveal the periodic trend for hyperconjugation in the chalcogens, which reflect a decreasing n x→σC-H(D) interaction throughout the period, as supported by IR spectroscopy and in agreement with DFT calculations and a natural bond order analysis.

Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors

-

Page/Page column 326; 327, (2016/03/19)

The invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.

INHIBITORS OF ACETYL-COA CARBOXYLASE

-

Page/Page column 86-88, (2010/11/17)

The present invention relates to compounds that act as acetyl-CoA carboxylase (ACC) inhibitors. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 22308-12-9